Unresectable Or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Unresectable Or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT06730932

A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor…

This study is A prospective，single arm, multicenter clinical study of BTLA monoclonal antibody JS004 (B/T lymphocyte attenuator factor monoclonal antibody) in c…

China31 participantsStarted 2025-10-30

Treatment: JS004（BTLA monoclonal antibody，intravenously）,Toripalimab（ anti-PD-1specific antibody，intravenously)